Meet our Medical Staff

Clinical Director and CEO, S. Edward Bradford, N.D., P.A.

EdS. Edward Bradford is the Clinical Director for the Immune Recovery Centers of America as well as their Atlanta clinic's Clinical and Managing Director. He received his Physician Assistant (PA) education at the University of Utah College of Medicine, Physician Assistant Program, Salt Lake City, Utah. He completed his internship in Las Vegas, Nevada and has practiced as a civilian Physician Assistant for more than 24 years. Mr. Bradford completed 22 ½ years of military service. Prior to his retirement from the armed forces, he served as a Senior Instructor at the United States Air Force School of Aerospace Medicine and as a Medical Air Crew Member with the Air Force Aero-Medical Evacuation System.

Mr. Bradford was the CEO of three out-patient primary care health facilities, which provided extensive care to indigent and gray area patients. Mr. Bradford is the recipient of the Howard County Maryland’s equivalent to the 1000 Points of Light Award for his outstanding contributions to community health care. He is certified by the National Commission on Certification of Physician Assistants (NCCPA) and is a member of the American Academy of Physician Assistants and the Georgia Association of Physician Assistants.

Director of Research, C. Richard Kinsolving, Ph.D.

CRKDr. Kinsolving is a pharmaceutical scientist as well as an executive. He was responsible for the development and registration approval of 10 new drug entities (NDAs) and four new formulations (ANDAs). He is the developer of the concept for non-sedating antihistamines and the designer of the first such drug, Seldane® (terfenadine), which reached $ 2+ billion in annual sales. He also is listed as the inventor on 17 issued  patents in the pharmaceutical area.Dr. Kinsolving also was a member of the research team (Post et. Al.) which discovered and named the Na+ / K+ transport ATPase enzyme , an important component of cell and nerve electrical transmission.

His writings have been published in more than 45 peer-reviewed journal articles; a list of Dr. Kinsolving's publications and patents may be found on this link. During the last few years, Dr. Kinsolving has dedicated himself to researching immunology in general, and the clinical application of immunology to cancer and other disease therapy, as the autoimmune diseases - rheumatoid arthritis and lupus. He is currently involved with research combining IAT modified conventional chemotherapy with immunotherapy and the combined use of transfer factor and vaccines. Much of this work has been in collaboration with Dr. Raymundo Diaz and Dra. Christina Rodriguez.

Dr. Kinsolving keeps the staff updated as to how we can employ new developments and technology in our treatments. He lectures the staff and holds Q & A sessions with the patients. He is also assembling a group of consultants to work with IRC in the emerging areas of Intensity Modulated Radiotherapy and Intra Arterial Therapy. Both of these innovations offer promise in refining the use of radiotherapy and chemotherapy respectively. This is of particular importance because these techniques can be used with immunotherapy if properly sequenced. The goal is to find ways to integrate new discoveries in conventional medicine with the clinic's work -  integrative medicine.

Research and medicine are almost synonymous. We are bombarded daily by the media with new research, giving the promise of dramatic cures (usually years away). This is the popular press. The real reports are found in the scientific press and are technical, dull, and generally presented as steps rather than a totally new therapy. New drugs reported are usually only a slight improvement in the current catalogue (they may be financially promising, however). IRC believes that we need to stay abreast of those new reports that may offer a positive impact on our therapeutic protocols, which we continually strive to improve. These reports may not reach the popular press. They involve studies on different ways to use existing agents, synergies seen with conventional drugs and immune agents - in short, ways to make our therapies more effective.

Ma. Cristina Rodriguez Padilla, Ph.D.

RodriguezDoctor Cristina Rodriguez Padilla is the Head of the Department of Microbiology and Immunology, and Head of the Laboratory of Virology and Immunology at the University of Autonoma de Nuevo Leon (UANL). Dr. Rodriguez  received her doctorate at the National Polytechnic Institute in Mexico City, Mexico.  She is the Coordinator of the Master Program specializing in Immunology of the school of Biological Sciences for the University Autonoma de Nuevo Leon in Monterrey, Mexico. Dr. Rodriguez has been a member of the Admissions Committee of the Masters Program specializing in Microbiology and Immunology.

Dr. Rodriguez has been internationally recognized for her scientific work within the University, particularly for her research in the development of T Lymphocytes and immuno-suppressive Cytokines. She is recognized internationally as one of the leading experts on Transfer Factor. Her laboratory produces Transfer Factor for worldwide use both therapeutically and for research. Additionally, she has conducted research in the Medical School Department of Surgery, San Antonio Health Science Center at the University Of Texas and the Harvard School of Public Health, Department of Cancer Biology for Safety in Laboratories Level 2 and 3.

Dr. Rodriguez holds one international patent, five national patents and has four national patents pending. She routinely presents scientific papers on her research in immunology and cancer at major scientific meetings and has an extensive list of publications.

Director of Nurses, Colleen Bradford, RN

ColleenFollowing receipt of her Registered Nursing (RN) license in 1989, Colleen S. Bradford joined the Oncology Team of the University of Maryland's Medical Center at Baltimore, where she had her introduction to the care and treatment of patients with cancer and chronic illnesses of the immune system.

Ms. Bradford's 14 years of nursing experience also include home health, staff school nursing, correctional medicine, as well as adolescent and adult psychiatric care. She has served as charge nurse in various nursing disciplines and as the Acting Director of Nursing for nine months at the Devereux Center of Georgia.

Clinical Coordinator and Quality Assurance, Lesley Harof, RN

LesleyMs. Lesley Harof is a Registered Nurse educated at New York University-Bellevue School of Nursing in New York City, New York. She has 13 years of Urological/Gyn/Oncology nursing experience with acute and chronic clinical roles with Emory University Hospital. She has spent the last 14 years as an Infusion Therapist in the field of Complementary Medicine specializing in providing individualized treatment programs for immunologically suppressed patients.

Ms. Harof is currently serving as Assistant Director of Nurses, Clinical Coordinator and is responsible for and committed to the Quality Assurance of the Immune Recovery Foundation.